Columbia Technology Ventures
Oncology
Search text
Active Filters
Hiroshi Nakagawa
2 results
(0.02 seconds)

This technology is a method to generate squamous epithelial 3D organoids that can mimic the natural physiology of tissues and be used as a personalized pathology model.

This technology describes a method to generate patient-derived oral cancer organoids, facilitating disease modeling and drug screening via a personalized medicine approach.